Skip to main content
Tech.euFundingExplorerBeta

MONDRAGON

Investor profile

Venture capital

MONDRAGON has backed 3 European tech companies across 3 funding rounds between 2023 and 2026, joining rounds totalling €4.0M. Most active in Foodtech and Healthtech. Data as of 4 Nov 2026.

Deals
3
distinct rounds
Companies
3
backed
Active span
2023–2026
4 yrs
Total round €
€4.0M
sum of rounds joined

Deals by year

distinct rounds / year
MONDRAGON — deals by year — interactive chart.
Data table
MONDRAGON — deals by year
20231
20262

Top sectors

by deals
MONDRAGON — top sectors — interactive chart.
Data table
MONDRAGON — top sectors
Foodtech1
Healthtech1
Cybersecurity1

Stages

by deals
MONDRAGON — stages — interactive chart.
Data table
MONDRAGON — stages
Other2
Growth/Late1

Countries

by deals
MONDRAGON — countries — interactive chart.
Data table
MONDRAGON — countries
Spain3

Co-investment network

shared rounds
Co-investment network — interactive chart.
MONDRAGON — 3 dealsMONDRAGONAmerican North South Ventures — 1 shared deals · click to openAmerican North South VenturesBasque Country Venture Capital Fund (Spri) — 1 shared deals · click to openBasque Country Venture Capital Fund (Spri)Basque Country Venture Capital Management — 1 shared deals · click to openBasque Country Venture Capital ManagementBexen Medical — 1 shared deals · click to openBexen MedicalCleon Capital — 1 shared deals · click to openCleon CapitalColumbus Venture Partners — 1 shared deals · click to openColumbus Venture PartnersIkerlan — 1 shared deals · click to openIkerlanSangha Capital — 1 shared deals · click to openSangha CapitalViscofan — 1 shared deals · click to openViscofan

Hover a node for shared-deal counts; click a co-investor to open its profile.

Best viewed on a larger screen.

Portfolio

top 30 by total round €
CompanyCountryRoundsTotal €
Cocoon BioscienceSpain1€2.0M
Orbik CybersecuritySpain1€2.0M
RemolonasSpain1€0

Biggest deals

top 10 by amount
CompanyStageAmountDate
Orbik CybersecurityGrowth/Late€2.0M2026-05
Cocoon BioscienceOther€2.0M2023-11
← Back to investors